Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years-Reference-Cited by-同舟云学术

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years

Published:2010-06 Issue:6 Volume:29 Page:e35-e46
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Díez-Domingo Javier,Garcés-Sanchez Maria,Baldó José-María,Planelles María Victoria,Ubeda Isabel,JuBert Angels,Marés Josep,Moris Philippe,Garcia-Corbeira Pilar,Dramé Mamadou,Gillard Paul

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference23 articles.

1. Social contact networks for the spread of pandemic influenza in children and teenagers.;Glass;BMC Public Health,2008

2. Children, avian influenza H5N1 and preparing for the next pandemic.;Nicoll;Arch Dis Child,2008

3. The economic impact of pandemic influenza in the United States: priorities for intervention.;Meltzer;Emerg Infect Dis,1999

4. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.;Mylius;Vaccine,2008

5. Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children.;Chotpitayasunondh;PLoS ONE,2008

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pandemic preparedness through vaccine development for avian influenza viruses;Human Vaccines & Immunotherapeutics;2024-05-28

2. Research progress on emulsion vaccine adjuvants;Heliyon;2024-02

3. New-age vaccine adjuvants, their development, and future perspective;Frontiers in Immunology;2023-02-24

4. Inactivated and Recombinant Influenza Vaccines;Plotkin's Vaccines;2023

5. An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives;Vaccines;2022-05-22